You are here

Article info

Article menu
Download PDFPDF
Screening
Original article
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation

Authors

  • Cinnamon S Bloss Scripps Genomic Medicine, Scripps Translational Science Institute, and Scripps Health, La Jolla, California, USA PubMed articlesGoogle scholar articles
  • Nicholas J Schork Scripps Genomic Medicine, Scripps Translational Science Institute, and Scripps Health, La Jolla, California, USA Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA PubMed articlesGoogle scholar articles
  • Eric J Topol Scripps Genomic Medicine, Scripps Translational Science Institute, and Scripps Health, La Jolla, California, USA Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA Scripps Clinic, La Jolla, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Cinnamon S Bloss, Scripps Translational Science Institute, 3344 N. Torrey Pines Court, Suite 300, La Jolla, California 92037, USA; cbloss{at}scripps.edu
View Full Text

Citation

Bloss CS, Schork NJ, Topol EJ
Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation
Journal of Medical Genetics 2014;51:83-89.

Publication history

  • Received July 3, 2013
  • Revised November 13, 2013
  • Accepted November 20, 2013
  • First published December 16, 2013.
Online issue publication 
October 11, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions